Literature DB >> 20143447

Ability of integrated positron emission and computed tomography to detect significant colonic pathology: the experience of a tertiary cancer center.

Brian R Weston1, Revathy B Iyer, Wei Qiao, Jeffrey H Lee, Robert S Bresalier, William A Ross.   

Abstract

BACKGROUND: The ability of integrated positron emission tomography and computed axial tomography (PET-CT) to detect colonic pathology is not fully defined. The purpose of this study was to assess the ability of PET-CT to detect colonic pathology and to determine the significance of ((18)F)2-fluoro-2-deoxyglucose ((18)F-FDG) activity noted incidentally in the colon on PET-CT.
METHODS: Records for all patients who underwent PET-CT and colonoscopy at our institution were reviewed. Patients with history of colonic malignancy or colon surgery were excluded.
RESULTS: Fifty-eight patients had incidental colonic (18)F-FDG activity on PET (Group A) and 272 had none (Group B). In Group A, 65% of patients had pathologic findings detected on colonoscopy that corresponded to the site of PET activity. Standardized uptake value (SUV) readings were not helpful in distinguishing true-positives from false-positives. In Group B, 11.8% of patients were found to have significant colonic findings. Lesions not detected by PET-CT included 4 colon cancers, 7 advanced adenomas, and 10 patients with colonic lymphoma. Overall, the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of PET-CT for detecting significant pathology were 53%, 93%, 65%, 89%, and 85%, respectively. For detecting colon cancer and adenomas 10 mm or more, the sensitivity, specificity, PPV, NPV, and accuracy of PET-CT were 72%, 90%, 45%, 96%, and 88%, respectively.
CONCLUSIONS: Incidental colonic activity detected by PET-CT warrants further evaluation with colonoscopy. However, negative PET-CT does not rule out significant colonic pathology including colon cancer, advanced adenomas, or lymphoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20143447     DOI: 10.1002/cncr.24885

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  23 in total

1.  The clinical significance of incidental intra-abdominal findings on positron emission tomography performed to investigate pulmonary nodules.

Authors:  Richdeep S Gill; Troy Perry; Jonathan T Abele; Eric L R Bédard; Daniel Schiller
Journal:  World J Surg Oncol       Date:  2012-01-27       Impact factor: 2.754

2.  Incidental 18F-FDG uptake in the colon: value of contrast-enhanced CT correlation with colonoscopic findings.

Authors:  Julian Kirchner; Benedikt M Schaarschmidt; Firas Kour; Lino M Sawicki; Ole Martin; Johannes Bode; Stephan Vom Dahl; Verena Keitel; Dieter Häussinger; Christina Antke; Christian Buchbender; Gerald Antoch; Philipp Heusch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-07       Impact factor: 9.236

3.  Detectability of colorectal neoplasia with fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT).

Authors:  Tomoko Hirakawa; Jun Kato; Yoshihiro Okumura; Keisuke Hori; Sakuma Takahashi; Hideyuki Suzuki; Mitsuhiro Akita; Reiji Higashi; Shunsuke Saito; Eisuke Kaji; Toshio Uraoka; Sakiko Hiraoka; Kazuhide Yamamoto
Journal:  J Gastroenterol       Date:  2011-10-08       Impact factor: 7.527

4.  Clinical significance of incidental colonic 18F-FDG uptake on PET/CT images in patients with gastric adenocarcinoma.

Authors:  Jung Ho Shim; Joo Hyun O; Seong Il Oh; Han Mo Yoo; Hae Myung Jeon; Cho Hyun Park; Sung Hoon Kim; Kyo Young Song
Journal:  J Gastrointest Surg       Date:  2012-06-30       Impact factor: 3.452

Review 5.  Positron emission tomographic scans in lymphoma: convention and controversy.

Authors:  Stephen M Ansell; James O Armitage
Journal:  Mayo Clin Proc       Date:  2012-06       Impact factor: 7.616

6.  Incidental colonic 18F-fluorodeoxyglucose uptake: do we need colonoscopy for patients with focal uptake confined to the left-sided colon?

Authors:  Changhyun Lee; Seong-Joon Koh; Ji Won Kim; Kook Lae Lee; Jong Pil Im; Sang Gyun Kim; Joo Sung Kim; Hyun Chae Jung; Byeong Gwan Kim
Journal:  Dig Dis Sci       Date:  2012-08-11       Impact factor: 3.199

7.  Use of FDG/PET CT to diagnose malignancy as the cause of mucocele of the appendix.

Authors:  Nilendu C Purandare; Arun Gandhi; Ameya D Puranik; Archi Agrawal; Sneha Shah; Asawari Patil; Venkatesh Rangarajan
Journal:  Indian J Gastroenterol       Date:  2013-08-28

8.  Sensitivity of 2-[18F]fluoro-2-deoxyglucose positron emission tomography for advanced colorectal neoplasms: a large-scale analysis of 7505 asymptomatic screening individuals.

Authors:  Masau Sekiguchi; Yasuo Kakugawa; Takashi Terauchi; Minori Matsumoto; Hiroshi Saito; Yukio Muramatsu; Yutaka Saito; Takahisa Matsuda
Journal:  J Gastroenterol       Date:  2016-03-28       Impact factor: 7.527

9.  Is there any additional benefit of contrast-enhanced CT as part of routine PET/CT protocols for the differentiation of suspicious incidental gastrointestinal 2-deoxy-(18)F-FDG uptake?

Authors:  Cornelia Bettina Brendle; Philip Aschoff; Thomas Kratt; Christina Schraml; Matthias Reimold; Claus Detlef Claussen; Christina Anna Pfannenberg
Journal:  Korean J Radiol       Date:  2013-11-05       Impact factor: 3.500

10.  Benign Colonic (18)F-FDG Uptake on Whole-Body FDG-PET Scan.

Authors:  Byung Ik Jang
Journal:  Clin Endosc       Date:  2012-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.